Search
for
Sort by
Research 931–960 of 1000+
- Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
- Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Trichomegaly of the eyelashes following treatment with cetuximab
- Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of <i>Retinoblastoma</i> and <i>Trp53</i> Tumor Suppressors
- Drugs and Hair Loss
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Cetuximab-Associated Elongation of the Eyelashes
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity of anti‐cancer therapy
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Dermatologic Reactions to Targeted Therapy
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Gefitinib-induced hair alterations: Figure 1
- Novel Application of Layered Expression Scanning for Proteomic Profiling of Plucked Hair Follicles
- Histochemistry of the porcine pilosebaceous unit